346 related articles for article (PubMed ID: 16870071)
21. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
22. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
23. Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
O'Connor RD; Gilmore AS; Manjunath R; Stanford RH; Legorreta AP; Jhingran PM
Curr Med Res Opin; 2006 Mar; 22(3):453-61. PubMed ID: 16574029
[TBL] [Abstract][Full Text] [Related]
24. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
25. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
Maspero JF; Dueñas-Meza E; Volovitz B; Pinacho Daza C; Kosa L; Vrijens F; Leff JA
Curr Med Res Opin; 2001; 17(2):96-104. PubMed ID: 11759189
[TBL] [Abstract][Full Text] [Related]
26. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
27. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
28. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
29. Relationship between pediatric primary provider visits and acute asthma ED visits.
Smith SR; Wakefield DB; Cloutier MM
Pediatr Pulmonol; 2007 Nov; 42(11):1041-7. PubMed ID: 17902163
[TBL] [Abstract][Full Text] [Related]
30. Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children.
Van Dole KB; Swern AS; Newcomb K; Nelsen L
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):198-204. PubMed ID: 19354065
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
[TBL] [Abstract][Full Text] [Related]
32. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
Zeiger RS; Szefler SJ; Phillips BR; Schatz M; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM;
J Allergy Clin Immunol; 2006 Jan; 117(1):45-52. PubMed ID: 16387583
[TBL] [Abstract][Full Text] [Related]
33. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
Bukstein DA; Henk HJ; Luskin AT
Clin Ther; 2001 Sep; 23(9):1589-600. PubMed ID: 11589270
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
36. The economic impact of children dispensed asthma medications without an asthma diagnosis.
Stempel DA; Spahn JD; Stanford RH; Rosenzweig JR; McLaughlin TP
J Pediatr; 2006 Jun; 148(6):819-23. PubMed ID: 16769395
[TBL] [Abstract][Full Text] [Related]
37. Adherence to montelukast versus inhaled corticosteroids in children with asthma.
Carter ER; Ananthakrishnan M
Pediatr Pulmonol; 2003 Oct; 36(4):301-4. PubMed ID: 12950042
[TBL] [Abstract][Full Text] [Related]
38. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
[TBL] [Abstract][Full Text] [Related]
39. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
Balkrishnan R; Nelsen LM; Kulkarni AS; Pleasants RA; Whitmire JT; Schechter MS
J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
[TBL] [Abstract][Full Text] [Related]
40. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
